|
|
|
|
|
|
|
|
|
| | — | | | (41) |
|
|
|
|
|
| | 136 | | | — | | | — | | | — | | | — | | | 11 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Impairment and other charges | 0.68 | | | 2.12 | | | | |
| Product recall-related impact | 0.07 | | | — | | | | |
Pension and retiree medical-related impact | 0.01 | | | 0.17 | | | | |
|
| Tax benefit related to the IRS audit | — | | | (0.23) | | | | |
Tax expense related to the TCJ Act | — | | | 0.06 | | | | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PepsiCo Common Shareholders’ Equity | | | |
Common stock, par value 12/3¢ per share (authorized shares; issued, net of repurchased common stock at par value: and shares, respectively) | | | | | |
Capital in excess of par value | | | | | |
Retained earnings | | | | | |
Accumulated other comprehensive loss | () | | | () | |
Repurchased common stock, in excess of par value ( and shares, respectively) | () | | | () | |
Total PepsiCo Common Shareholders’ Equity | | | | | |
| Noncontrolling interests | | | | | |
Total Equity | | | | | |
| Total Liabilities and Equity | $ | | | | $ | | |
See accompanying notes to the consolidated financial statements.
Consolidated Statement of Equity
PepsiCo, Inc. and Subsidiaries
Fiscal years ended December 30, 2023, December 31, 2022 and December 25, 2021
(in millions except per share amounts)
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | 2023 | | 2022 | | 2021 |
| | Shares | | Amount | | Shares | | Amount | | Shares | | Amount |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
| Common Stock | | | | | | | | | | | |
| Balance, beginning of year | | | | $ | | | | | | | $ | | | | | | | $ | | |
| Change in repurchased common stock | () | | | | | | () | | | | | | | | | | |
| Balance, end of year | | | | | | | | | | | | | | | | | |
| Capital in Excess of Par Value | | | | | | | | | | | |
| Balance, beginning of year | | | | | | | | | | | | | | |
| Share-based compensation expense | | | | | | | | | | | | | | |
| Stock option exercises, RSUs and PSUs converted | | | () | | | | | () | | | | | () | |
| Withholding tax on RSUs and PSUs converted | | | () | | | | | () | | | | | () | |
| Other | | | () | | | | | () | | | | | () | |
| Balance, end of year | | | | | | | | | | | | | | |
| Retained Earnings | | | | | | | | | | | |
| Balance, beginning of year | | | | | | | | | | | | | | |
| | | | |
| Net income attributable to PepsiCo | | | | | | | | | | | | | | |
Cash dividends declared - common (a) | | | () | | | | | () | | | | | () | |
| Balance, end of year | | | | | | | | | | | | | | |
| Accumulated Other Comprehensive Loss | | | | | | | | | | | |
| Balance, beginning of year | | | () | | | | | () | | | | | () | |
| Other comprehensive (loss)/income attributable to PepsiCo | | | () | | | | | () | | | | | | |
| Balance, end of year | | | () | | | | | () | | | | | () | |
| Repurchased Common Stock | | | | | | | | | | | |
| Balance, beginning of year | () | | | () | | | () | | | () | | | () | | | () | |
| Share repurchases | () | | | () | | | () | | | () | | | () | | | () | |
| Stock option exercises, RSUs and PSUs converted | | | | | | | | | | | | | | | | | |
| Other | | | | | | | | | | | | | | | | | |
| Balance, end of year | () | | | () | | | () | | | () | | | () | | | () | |
| Total PepsiCo Common Shareholders’ Equity | | | | | | | | | | | | | | |
| Noncontrolling Interests | | | | | | | | | | | |
| Balance, beginning of year | | | | | | | | | | | | | | |
| Net income attributable to noncontrolling interests | | | | | | | | | | | | | | |
| Distributions to noncontrolling interests | | | () | | | | | () | | | | | () | |
| | | | |
| Acquisitions | | | | | | | | | | | | | | |
| Other, net | | | () | | | | | () | | | | | () | |
| Balance, end of year | | | | | | | | | | | | | | |
| Total Equity | | | $ | | | | | | $ | | | | | | $ | | |
, $ and $ for 2023, 2022 and 2021, respectively.
See accompanying notes to the consolidated financial statements.
Notes to the Consolidated Financial Statements
Note 1 —
% or less. Intercompany balances and transactions are eliminated. As a result of exchange restrictions and other operating restrictions, we do not have control over our Venezuelan subsidiaries. As such, our Venezuelan subsidiaries are not included within our consolidated financial results for any period presented.Raw materials, direct labor and plant overhead, as well as purchasing and receiving costs, costs directly related to production planning, inspection costs and raw materials handling facilities, are included in cost of sales. The costs of moving, storing and delivering finished product, including merchandising activities, are included in selling, general and administrative expenses.
| Second Quarter | | 12 weeks | | |
| Third Quarter | | 12 weeks | | |
| Fourth Quarter | | 16 weeks (17 weeks for 2022) | | |
Unless otherwise noted, tabular dollars are in millions, except per share amounts. All per share amounts reflect common per share amounts, assume dilution unless otherwise noted, and are based on unrounded amounts. Certain reclassifications were made to the prior year’s consolidated financial statements to conform to the current year presentation.
reportable segments (also referred to as divisions), as follows:
1)Frito-Lay North America (FLNA), which includes our branded convenient food businesses in the United States and Canada;
2)Quaker Foods North America (QFNA), which includes our branded convenient food businesses, such as cereal, rice, pasta and other branded food, in the United States and Canada;
3)PepsiCo Beverages North America (PBNA), which includes our beverage businesses in the United States and Canada;
4)Latin America (LatAm), which includes all of our beverage and convenient food businesses in Latin America;
5)Europe, which includes all of our beverage and convenient food businesses in Europe;
6)Africa, Middle East and South Asia (AMESA), which includes all of our beverage and convenient food businesses in Africa, the Middle East and South Asia; and
7)Asia Pacific, Australia and New Zealand and China region (APAC), which includes all of our beverage and convenient food businesses in Asia Pacific, Australia and New Zealand, and China region.
Through our operations, authorized bottlers, contract manufacturers and other third parties, we make, market, distribute and sell a wide variety of beverages and convenient foods, serving customers and consumers in more than countries and territories with our largest operations in the United States, Mexico, Canada, Russia, China, the United Kingdom, Brazil and South Africa.
The accounting policies for the divisions are the same as those described in Note 2, except for the following allocation methodologies:
•share-based compensation expense;
•pension and retiree medical expense; and
•derivatives.
Share-Based Compensation Expense
Our divisions are held accountable for share-based compensation expense and, therefore, this expense is allocated to our divisions as an incremental employee compensation cost.
% | | | % | | | % | | QFNA | | % | | | % | | | % |
| PBNA | | % | | | % | | | % |
| LatAm | | % | | | % | | | % |
| Europe | | % | | | % | | | % |
| AMESA | | % | | | % | | | % |
| APAC | | % | | | % | | | % |
| Corporate unallocated expenses | | % | | | % | | | % |
The expense allocated to our divisions excludes any impact of changes in our assumptions during the year which reflect market conditions over which division management has no control. Therefore, any variances between allocated expense and our actual expense are recognized in corporate unallocated expenses.
| | $ | | | | $ | | | | $ | | | | $ | | | | $ | | | QFNA (b) | | | | | | | | | | | | | | | | | |
PBNA (c) | | | | | | | | | | | | | | | | | |
| LatAm | | | | | | | | | | | | | | | | | |
Europe (c) | | | | | | | | | | | | | () | | | | |
| AMESA | | | | | | | | | | | | | | | | | |
| APAC | | | | | | | | | | | | | | | | | |
| Total division | | | | | | | | | | | | | | | | | |
| Corporate unallocated expenses | | | | | | | | | | () | | | () | | | () | |
| Total | $ | | | | $ | | | | $ | | | | $ | | | | $ | | | | $ | | |
(a)See below for impairment and other charges taken related to the Russia-Ukraine conflict, brand portfolio impairment and other impairment.
(b)In 2023, operating profit included a pre-tax charge of $ million ($ million after-tax or $ per share) in cost of sales for product returns, inventory write-offs and customer and consumer-related costs associated with the Quaker Recall.
(c)In 2022, we recorded a gain of $ million and $ million in our PBNA and Europe divisions, respectively, associated with the Juice Transaction. The total after-tax amount was $ million or $ per share. See Note 13 for further information.
| % | | | % | | | % | | | % | | | % | | | % | | Europe | | % | | | % | | | % | | | % | | | % | | | % |
| AMESA | | % | | | % | | | % | | | % | | | % | | | % |
| APAC | | % | | | % | | | % | | | % | | | % | | | % |
| PepsiCo | | % | | | % | | | % | | | % | | | % | | | % |
| | | | |
| | | | |
| | |
|
| | |
|
| | | | | | | | | | Loss on sale and impairment of intangible assets related to the sale of certain non-strategic brands |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | |
| | | | | | | | | | Impairment of property, plant and equipment related to the discontinuation of a non-strategic brand in China |
| | | | | | | | | |
| () | | |
| | | | | | | | | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| | |
Severance and other employee costs primarily include severance and other termination benefits, as well as voluntary separation arrangements. Other costs primarily include costs associated with the implementation of our initiatives, including consulting and other professional fees, as well as contract termination costs.
| | $ | | | | $ | | | | $ | | | | 2021 restructuring charges | | | | | | | | | | | |
Cash payments (a) | () | | | | | | () | | | () | |
| Non-cash charges and translation | () | | | () | | | | | | () | |
| Liability as of December 25, 2021 | | | | | | | | | | | |
| 2022 restructuring charges | | | | | | | | | | | |
Cash payments (a) | () | | | | | | () | | | () | |
| Non-cash charges and translation | () | | | () | | | | | | () | |
Liability as of December 31, 2022 | | | | | | | | | | | |
| 2023 restructuring charges | | | | | | | | | | | |
Cash payments (a) | () | | | | | | () | | | () | |
| Non-cash charges and translation | () | | | () | | | () | | | () | |
Liability as of December 30, 2023 | $ | | | | $ | | | | $ | | | | $ | | |
(a)Excludes cash expenditures of $ million in 2023, $ million in 2022 and $ million in 2021, reported in the cash flow statement in pension and retiree medical plan contributions.
The majority of the restructuring accrual at December 30, 2023 is expected to be paid by the end of 2024.
Other Productivity Initiatives
There were material charges related to other productivity and efficiency initiatives outside the scope of the 2019 Productivity Plan.
We regularly evaluate different productivity initiatives beyond the productivity plan and other initiatives described above.
For information on additional impairment charges, see Notes 1, 4 and 9 for impairment and other charges taken related to the Russia-Ukraine conflict, brand portfolio impairment charges and other impairment charges.
Note 4 —
– | $ | | | | $ | () | | | $ | | | | $ | | | | $ | () | | | $ | | | | | Customer relationships | – | | | | | () | | | | | | | | | () | | | | | | |
| Brands | – | | | | | () | | | | | | | | | () | | | | | | |
| Other identifiable intangibles | – | | | | | () | | | | | | | | | () | | | | | | |
| Total | | | $ | | | | $ | () | | | $ | | | | $ | | | | $ | () | | | $ | | | | |
| Amortization expense | | | | | | | $ | | | | | | | | $ | | | | $ | | |
| | $ | | | | $ | | | | $ | | | | $ | | | Indefinite-Lived Intangible Assets
As discussed in Note 2, we perform our annual impairment assessment on indefinite-lived intangible assets during our third quarter. The annual impairment assessment on indefinite-lived intangible assets performed in the third quarter of 2023, based on best available market information and our internal forecasts and operating plans at the time, did not result in any material impairment charges.
In the fourth quarter of 2023, macroeconomic conditions, including higher interest rates, inflationary costs, and the ongoing conflict in the Middle East, and recent business performance indicated a deterioration of the significant inputs used to determine the fair value of our indefinite-lived intangible assets in various markets, primarily assumptions underlying the weighted-average cost of capital and the impact of economic uncertainty on current and future financial performance, and required us to perform a quantitative assessment on certain assets. The fair value of our indefinite-lived intangible assets was estimated using discounted cash flows under the income approach, which we consider to be a Level 3 measurement. We determined that the carrying value exceeded the fair value, which reflects the increase in the weighted-average cost of capital as well as our most current estimates of future sales and their contributions to operating profit and expected future cash flows (including perpetuity growth assumptions). As a result of the quantitative assessment, we recorded pre-tax impairment charges of $ billion ($ billion after-tax or $ per share) for brands and $ billion ($ billion after-tax or $ per share) for goodwill, both in impairment of intangible assets, primarily related to the SodaStream brand and reporting unit in our Europe division, in the year ended December 30, 2023. See Note 1 for further information.
In the first quarter of 2022, we discontinued or repositioned certain juice and dairy brands in Russia in our Europe division. As a result, we recognized pre-tax impairment charges (included in brand portfolio impairment charges) of $ million ($ million after-tax or $ per share) in impairment of intangible assets, primarily related to indefinite-lived intangible assets in the year ended December 31, 2022. See Note 1 for further information.
In the second quarter of 2022, macroeconomic factors, sanctions and other regulations as a result of the Russia-Ukraine conflict indicated a material deterioration of the significant inputs used to determine the fair value of our indefinite-lived intangible assets in Russia, primarily assumptions underlying the weighted-average cost of capital. These factors required us to perform a quantitative assessment, despite the absence of a material adverse impact on these assets’ financial performance (e.g., sales, operating profit, cash flows). The fair value of our indefinite-lived intangible assets in Russia was estimated using discounted cash flows under the income approach, which we consider to be a Level 3 measurement. We determined that the carrying value exceeded the fair value, with the decrease in the fair value primarily attributable to a significant increase in the weighted-average cost of capital, which reflected the macroeconomic uncertainty in Russia. As a result of the quantitative assessment, we recorded pre-tax
billion ($ million after-tax or $ per share) in impairment of intangible assets, related to our juice and dairy brands in Russia in our Europe division, in the year ended December 31, 2022. See Note 1 for further information. In the fourth quarter of 2022, macroeconomic conditions including a high interest rate and inflationary cost environment, coupled with recent business performance, indicated a deterioration of the significant inputs used to determine the fair value of our indefinite-lived intangible assets in various markets, primarily assumptions underlying the weighted-average cost of capital and the impact of economic uncertainty on current and future financial performance, and required us to perform a quantitative assessment on certain assets. The fair value of our indefinite-lived intangible assets was estimated using discounted cash flows under the income approach, which we consider to be a Level 3 measurement. We determined that the carrying value exceeded the fair value, which reflected the increase in the weighted-average cost of capital as well as our most current estimates of future sales and their contributions to operating profit and expected future cash flows (including perpetuity growth assumptions). As a result of the quantitative assessment, we recognized pre-tax impairment charges of $ billion ($ billion after-tax or $ per share) in impairment of intangible assets, primarily related to the SodaStream brand in our Europe division, in the year ended December 31, 2022. See Note 1 for further information.
We did recognize any impairment charges for goodwill in each of the years ended December 31, 2022 and December 25, 2021. We did recognize any impairment charges for indefinite-lived intangible assets in the year ended December 25, 2021.
As of December 30, 2023, the estimated fair values of our indefinite-lived reacquired and acquired franchise rights recorded at PBNA exceeded their carrying values. However, there could be an impairment of the carrying value of PBNA’s reacquired and acquired franchise rights, as well as further impairment to the carrying value of the SodaStream reporting unit goodwill, if future sales and their contributions to operating profit do not achieve our expected future cash flows (including perpetuity growth assumptions) or if macroeconomic conditions result in a future increase in the weighted-average cost of capital used to estimate fair value.
For further information on our policies for indefinite-lived intangible assets, see Note 2.
| | $ | | | | $ | | | | $ | () | | | $ | | | | $ | | | | $ | | | | $ | | | | $ | | | Brands (a) | | | | | | | () | | | () | | | | | | | | | | | | | | | | |
| Total | | | | | | | () | | | () | | | | | | | | | | | | | | | | |
| QFNA | | | | | | | | | | | | | | | | | |
| Goodwill | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | |
| Total | | | | | | | | | | | | | | | | | | | | | | | | | | |
PBNA | | | | | | | | | | | | | | | | | |
| Goodwill | | | | | | | | | | () | | | | | | | | | | | | | | | | |
| Reacquired franchise rights | | | | | | | | | | () | | | | | | | | | | | | | | | | |
Acquired franchise rights (b) | | | | | | | | | | () | | | | | | | | | | | | () | | | | |
Brands | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Total | | | | | | | | | | () | | | | | | | | | | | | () | | | | |
| LatAm | | | | | | | | | | | | | | | | | |
| Goodwill | | | | | | | | | | | | | | | | | | | | | | | | | | |
Brands (c) | | | | | | | () | | | | | | | | | | | | | | | | | | | |
| Total | | | | | | | () | | | | | | | | | | | | | | | | | | | |
Europe | | | | | | | | | | | | | | | | | |
Goodwill (d)(e) | | | | | | | | | | () | | | | | | | | | () | | | () | | | | |
| Reacquired franchise rights | | | | | | | | | | () | | | | | | | | | | | | () | | | | |
Acquired franchise rights | | | | | | | () | | | () | | | | | | | | | | | | | | | | |
Brands (e) | | | | | | | () | | | | | | | | | | | | () | | | | | | | |
| Total | | | | | | | () | | | | | | | | | | | | () | | | () | | | | |
| AMESA | | | | | | | | | | | | | | | | | |
| Goodwill | | | | | | | | | | () | | | | | | | | | | | | () | | | | |
Brands (f) | | | | | | | () | | | () | | | | | | | | | () | | | () | | | | |
| Total | | | | | | | () | | | () | | | | | | | | | () | | | () | | | | |
| APAC | | | | | | | | | | | | | | | | | |
| Goodwill | | | | | | | | | | () | | | | | | | | | | | | () | | | | |
Brands (g) | | | | | | | () | | | () | | | | | | | | | () | | | () | | | | |
| Total | | | | | | | () | | | () | | | | | | | | | () | | | () | | | | |
| | | | | | | | | | | | | | | | | |
| Total goodwill | | | | | | | | | | () | | | | | | | | | () | | | () | | | | |
| Total reacquired franchise rights | | | | | | | | | | () | | | | | | | | | | | | | | | | |
| Total acquired franchise rights | | | | | | | () | | | () | | | | | | | | | | | | () | | | | |
| Total brands | | | | | | | () | | | | | | | | | | | | () | | | | | | | |
| Total | $ | | | | $ | | | | $ | () | | | $ | () | | | $ | | | | $ | | | | $ | () | | | $ | () | | | $ | | |
(a)Impairment in 2022 is related to a baked fruit convenient food brand.
(b)Acquisitions in 2022 primarily reflect our agreement with Celsius to distribute Celsius energy drinks in the United States. Translation and other in 2023 primarily reflects adjustments to previously recorded amounts related to our agreement with Celsius. See Note 9 for further information.
(c)Impairment in 2022 is related to the sale of certain non-strategic brands. See Note 1 for further information.
(d)Translation and other in 2023 primarily reflects the depreciation of the Russian ruble, partially offset by appreciation of the euro and British pound.
(e)Impairment in 2022 is related to the SodaStream brand, the decrease in fair value as a result of the Russia-Ukraine conflict and the discontinuation or repositioning of certain juice and dairy brands in Russia. Impairments in 2023 are related to SodaStream goodwill and brand.
Note 5 —
| | $ | | | | $ | | | | Foreign | | | | | | | | | |
| | $ | | | | $ | | | | $ | | |
| | $ | | | | $ | | | | Foreign | | | | | | | | |
| State | | | | | | | | |
| | | | | | | | |
| Deferred: | | | | | |
| U.S. Federal | () | | | | | | | |
| Foreign | () | | | () | | | () | |
| State | () | | | | | | | |
| () | | | () | | | | |
| $ | | | | $ | | | | $ | | |
% | | | % | | | % | | State income tax, net of U.S. Federal tax benefit | | | | | | | | |
| Lower taxes on foreign results | () | | | () | | | () | |
| One-time mandatory transition tax - TCJ Act | | | | | | | | |
|
| Juice Transaction | () | | | () | | | | |
| Tax settlements | | | | () | | | | |
| Other, net | () | | | () | | | () | |
| Annual tax rate | | % | | | % | | | % |
Tax Cuts and Jobs Act
In 2022, we recorded $ million ($ per share) of net tax expense related to the TCJ Act as a result of correlating adjustments related to a partial audit settlement with the IRS for tax years 2014 through 2019. In 2021, we recorded $ million ($ per share) of net tax expense related to the TCJ Act as a result of adjustments related to the final assessment of the 2014 through 2016 IRS audit.
As of December 30, 2023, our mandatory transition tax liability was $ billion, which must be paid through 2026 under the provisions of the TCJ Act. We reduced our liability through cash payments and application of tax overpayments by $ million in each of 2023, 2022 and 2021. We currently expect to pay approximately $ million of this liability in 2024.
million ($ per share) in 2021.In 2022, we came to an agreement with the IRS to settle one of the issues assessed in the 2014 through 2016 tax audit. The agreement covers tax years 2014 through 2019. As a result, we reduced our reserves for uncertain tax positions, including any correlating adjustments impacting the mandatory transition tax liability under the TCJ Act, resulting in a net non-cash tax benefit of $ million ($ per share) in 2022. Tax years 2014 through 2019 remain under audit for other issues.
| | $ | | | | Property, plant and equipment | | | | | |
| Recapture of net operating losses | | | | | |
| Pension liabilities | | | | | |
| Right-of-use assets | | | | | |
| Investment in TBG | | | | | |
| Other | | | | | |
| Gross deferred tax liabilities | | | | | |
| | | |
| Deferred tax assets | | | |
| Net carryforwards | | | | | |
| Intangible assets other than nondeductible goodwill | | | | | |
| Share-based compensation | | | | | |
| Retiree medical benefits | | | | | |
| Other employee-related benefits | | | | | |
|
| Deductible state tax and interest benefits | | | | | |
| Lease liabilities | | | | | |
| Capitalized research and development | | | | | |
| Other | | | | | |
| Gross deferred tax assets | | | | | |
| Valuation allowances | () | | | () | |
| Deferred tax assets, net | | | | | |
| Net deferred tax (assets)/liabilities | $ | () | | | $ | () | |
A summary of our valuation allowance activity is as follows:
| | | | | | | | | | | | | | | | | |
| 2023 | | 2022 | | 2021 |
| Balance, beginning of year | $ | | | | $ | | | | $ | | |
| Provision | | | | | | | () | |
| Other (deductions)/additions | | | | () | | | () | |
| Balance, end of year | $ | | | | $ | | | | $ | | |
As of December 30, 2023, the total gross amount of reserves for income taxes, reported in other liabilities, was $ billion. We accrue interest related to reserves for income taxes in our provision for income taxes and any associated penalties are recorded in selling, general and administrative expenses. The gross amount of interest accrued, reported in other liabilities, was $ million as of December 30, 2023, of which $ million of tax expense was recognized in 2023. The gross amount of interest accrued, reported in other liabilities, was $ million as of December 31, 2022, of which $ million of tax benefit was recognized in 2022.
| | $ | | | | Additions for tax positions related to the current year | | | | | |
| Additions for tax positions from prior years | | | | | |
| Reductions for tax positions from prior years | () | | | () | |
| Settlement payments | () | | | () | |
| Statutes of limitations expiration | () | | | () | |
| Translation and other | () | | | () | |
| Balance, end of year | $ | | | | $ | | |
Carryforwards and Allowances
Operating loss carryforwards and income tax credits totaling $ billion as of December 30, 2023 are being carried forward in a number of foreign and state jurisdictions where we are permitted to use tax operating losses and income tax credits from prior periods to reduce future taxable income or income tax liabilities. These operating losses and income tax credits will expire as follows: $ billion in 2024, $
billion may be carried forward indefinitely. We establish valuation allowances for our deferred tax assets if, based on the available evidence, it is not more likely than not that some portion or all of the deferred tax assets will be realized.Undistributed International Earnings
As of December 30, 2023, we had approximately $ billion of undistributed international earnings. We intend to continue to reinvest $ billion of earnings outside the United States for the foreseeable future and while future distribution of these earnings would not be subject to U.S. federal tax expense, no deferred tax liabilities with respect to items such as certain foreign exchange gains or losses, foreign withholding taxes or state taxes have been recognized. It is not practicable for us to determine the amount of unrecognized tax expense on these reinvested international earnings.
Note 6 —
stock options for every RSU that would have otherwise been granted. Certain executive officers and other senior executives do not have a choice and are granted % PSUs and % long-term cash, each of which are subject to pre-established performance targets. The Company may use authorized and unissued shares to meet share requirements resulting from the exercise of stock options and the vesting of RSUs and PSUs.
As of December 30, 2023, million shares were available for future share-based compensation grants under the LTIP.
| | $ | | | | $ | | | | Share-based compensation expense - liability awards | | | | | | | | |
| Acquisition and divestiture-related charges | | | | | | | | |
| Restructuring charges | () | | | | | | | |
| Total | $ | | | | $ | | | | $ | | |
| Income tax benefits recognized in earnings related to share-based compensation | $ | | | | $ | | | | $ | | |
Excess tax benefits related to share-based compensation | $ | | | | $ | | | | $ | | |
As of December 30, 2023, there was $ million of total unrecognized compensation cost related to nonvested share-based compensation grants. This unrecognized compensation cost is expected to be recognized over a weighted-average period of .
Method of Accounting and Our Assumptions
. Awards to employees eligible for retirement prior to the award becoming fully vested are amortized to expense over the period through the date that the employee first becomes eligible to retire and is no
Stock Options
A stock option permits the holder to purchase shares of PepsiCo common stock at a specified price. We account for our employee stock options under the fair value method of accounting using a Black-Scholes valuation model to measure stock option expense at the date of grant. All stock option grants have an exercise price equal to the fair market value of our common stock on the date of grant and generally have a -year term.
years | years | | years | | Risk-free interest rate | | % | | | % | | | % |
| Expected volatility | | % | | | % | | | % |
| Expected dividend yield | | % | | | % | | | % |
The expected life is the period over which our employee groups are expected to hold their options. It is based on our historical experience with similar grants. The risk-free interest rate is based on the expected U.S. Treasury rate over the expected life. Volatility reflects movements in our stock price over the most recent historical period equivalent to the expected life. Dividend yield is estimated over the expected life based on our stated dividend policy and forecasts of net income, share repurchases and stock price.
| | $ | | | | | | | | Granted | | | | $ | | | | | | |
| Exercised | () | | | $ | | | | | | |
| Forfeited/expired | () | | | $ | | | | | | |
| Outstanding at December 30, 2023 | | | | $ | | | | | | $ | | |
| Exercisable at December 30, 2023 | | | | $ | | | | | | $ | | |
| Expected to vest as of December 30, 2023 | | | | $ | | | | | | $ | | |
(a)In thousands.
| | $ | | | | | | | | Granted | | | | $ | | | | | | |
| Converted | () | | | $ | | | | | | |
| Forfeited | () | | | $ | | | | | | |
Outstanding at December 30, 2023 (b) | | | | $ | | | | | | $ | | |
Expected to vest as of December 30, 2023 (c) | | | | $ | | | | | | $ | | |
(a)In thousands. Outstanding awards are disclosed at target.
(b)The outstanding PSUs for which the vesting period has not ended as of December 30, 2023, at the threshold, target and maximum award levels were , million and million, respectively.
(c)Represents the number of outstanding awards expected to vest, including estimated performance adjustments on all outstanding PSUs as of December 30, 2023.
Long-Term Cash
Certain executive officers and other senior executives were granted long-term cash awards for which final payout is based on PepsiCo’s total shareholder return relative to a specific set of peer companies and achievement of a specified performance target over a three-year performance period.
Long-term cash awards that qualify as liability awards under share-based compensation guidance are valued through the end of the performance period on a mark-to-market basis using the Monte Carlo simulation model.
| | | | | | Granted | | | | | | |
| Vested | () | | | | | |
| Forfeited | () | | | | | |
Outstanding at December 30, 2023 (c) | $ | | | | $ | | | | |
| Expected to vest as of December 30, 2023 | $ | | | | $ | | | | |
(a)In thousands, disclosed at target.
(b)In thousands, based on the most recent valuation as of December 30, 2023.
(c)The outstanding awards for which the vesting period has not ended as of December 30, 2023, at the threshold, target and maximum award levels based on the achievement of its market conditions were , $ million and $ million, respectively.
Other Share-Based Compensation Data
| | | | | | | | Weighted-average grant-date fair value per unit of options granted | $ | | | | $ | | | | $ | | |
Total intrinsic value of options exercised (a) | $ | | | | $ | | | | $ | | |
Total grant-date fair value of options vested (a) | $ | | | | $ | | | | $ | | |
| RSUs/PSUs | | | | | |
Total number of RSUs/PSUs granted (a) | | | | | | | | |
| Weighted-average grant-date fair value per unit of RSUs/PSUs granted | $ | | | | $ | | | | $ | | |
Total intrinsic value of RSUs/PSUs converted (a) | $ | | | | $ | | | | $ | | |
Total grant-date fair value of RSUs/PSUs vested (a) | $ | | | | $ | | | | $ | | |
|
|
(a)In thousands.
As of December 30, 2023 and December 31, 2022, there were approximately and outstanding awards, respectively, consisting primarily of phantom stock units that were granted under the PepsiCo Director Deferral Program and will be settled in shares of PepsiCo common stock pursuant to the LTIP at the end of the applicable deferral period, not included in the tables above.
Note 7 —
million and related assets to TBG in connection with the Juice Transaction. See Note 13 for further information.In 2021, we adopted a change to the Canadian defined benefit plans to freeze pension accruals for salaried participants, effective January 1, 2024, and to close the hourly plan to new non-union employees hired on or after January 1, 2022. After the effective date, all salaried participants receive an employer contribution to the defined contribution plan based on age and years of service regardless of employee contribution and the opportunity to receive employer contributions to match employee contributions up to defined limits. We also adopted a change to the U.K. defined benefit plan to freeze pension accruals for all participants effective March 31, 2022. After the effective date, participants have the opportunity to receive employer contributions to match employee contributions up to defined limits. Pre-tax pension benefits expense will decrease after the effective dates, partially offset by contributions to defined contribution plans.
In 2021, we adopted a change to the U.S. qualified defined benefit plans to transfer certain participants from Plan A to Plan I, effective January 1, 2022. The accrued benefits offered to the plans’ participants were unchanged. There was no material impact to pre-tax pension benefits expense from this transaction.
In 2020, we adopted an amendment to the U.S. qualified defined benefit plans to freeze benefit accruals for salaried participants, effective December 31, 2025.
% of the greater of the market-related value of plan assets or plan obligations, a portion of the net gain or loss is included in other pension and retiree medical benefits income for the following year based upon the average remaining service life for participants in PepsiCo Employees Retirement Hourly Plan (Plan H) (approximately years) and retiree medical (approximately years), and the remaining life expectancy for participants in Plan I (approximately years).The cost or benefit of plan changes that increase or decrease benefits for prior employee service (prior service cost/(credit)) is included in other pension and retiree medical benefits income on a straight-line basis over the average remaining service life for participants in Plan H, and the remaining life expectancy for participants in Plan I, except that prior service cost/(credit) for salaried participants subject to the benefit accruals freeze effective December 31, 2025 is amortized on a straight-line basis over the period up to the effective date of the freeze.
| | $ | | | | $ | | | | $ | | | | $ | | | | $ | | |
| Service cost | | | | | | | | | | | | | | | | | |
| Interest cost | | | | | | | | | | | | | | | | | |
| Plan amendments | | | | | | | | | | | | | | | | | |
| Participant contributions | | | | | | | | | | | | | | | | | |
| Experience loss/(gain) | | | | () | | | | | | () | | | () | | | () | |
| Benefit payments | () | | | () | | | () | | | () | | | () | | | () | |
| Settlement/curtailment | () | | | () | | | () | | | () | | | | | | () | |
| Special termination benefits | () | | | | | | | | | | | | | | | | |
| Other, including foreign currency adjustment | () | | | () | | | | | | () | | | | | | () | |
| Obligation at end of year | $ | | | | $ | | | | $ | | | | $ | | | | $ | | | | $ | | |
| | | | | | | | | | | |
| Change in fair value of plan assets | | | | | | | | | | | |
| Fair value at beginning of year | $ | | | | $ | | | | $ | | | | $ | | | | $ | | | | $ | | |
| Actual return on plan assets | | | | () | | | | | | () | | | | | | () | |
| Employer contributions/funding | | | | | | | | | | | | | | | | | |
| Participant contributions | | | | | | | | | | | | | | | | | |
| Benefit payments | () | | | () | | | () | | | () | | | () | | | () | |
| Settlement | () | | | () | | | () | | | () | | | | | | | |
| Other, including foreign currency adjustment | | | | () | | | | | | () | | | | | | () | |
| Fair value at end of year | $ | | | | $ | | | | $ | | | | $ | | | | $ | | | | $ | | |
| Funded status | $ | () | | | $ | () | | | $ | | | | $ | | | | $ | () | | | $ | () | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
|
|
| | | | |
| Amounts recognized | | | | | | | | | | | |
| Other assets | $ | | | | $ | | | | $ | | | | $ | | | | $ | | | | $ | | |
| Other current liabilities | () | | | () | | | () | | | () | | | () | | | () | |
| Other liabilities | () | | | () | | | () | | | () | | | () | | | () | |
| Net amount recognized | $ | () | | | $ | () | | | $ | | | | $ | | | | $ | () | | | $ | () | |
| | | | | | | | | | | |
| Amounts included in accumulated other comprehensive loss (pre-tax) | | | | | | | | |
| Net loss/(gain) | $ | | | | $ | | | | $ | | | | $ | | | | $ | () | | | $ | () | |
| Prior service cost/(credit) | | | | () | | | () | | | () | | | () | | | () | |
| Total | $ | | | | $ | | | | $ | | | | $ | | | | $ | () | | | $ | () | |
| | | | | | | | | | | |
| Changes recognized in net (gain)/loss included in other comprehensive loss | | |
| Net loss/(gain) arising in current year | $ | | | | $ | | | | $ | | | | $ | () | | | $ | () | | | $ | () | |
| Amortization and settlement recognition | () | | | () | | | () | | | () | | | | | | | |
| Foreign currency translation loss/(gain) | | | | | | | | | | () | | | | | | | |
| Total | $ | | | | $ | () | | | $ | | | | $ | () | | | $ | () | | | $ | () | |
| | | | | | | | | | | |
| Accumulated benefit obligation at end of year | $ | | | | $ | | | | $ | | | | $ | | | | | | |
The net loss arising in the current year is primarily attributable to the impact of lower discount rates, partially offset by an increase in the actual return on plan assets.
| | $ | | | | $ | | | | $ | | | | $ | | | | $ | | | | $ | | | | $ | | | | $ | | | | Other pension and retiree medical benefits (income)/expense: | | | | | | | | | | | | | | | | |
| Interest cost | $ | | | | $ | | | | $ | | | | $ | | | | $ | | | | $ | | | | $ | | | | $ | | | | $ | | |
| Expected return on plan assets | () | | | () | | | () | | | () | | | () | | | () | | | () | | | () | | | () | |
| Amortization of prior service credits | () | | | () | | | () | | | () | | | () | | | () | | | () | | | () | | | () | |
| Amortization of net losses/(gains) | | | | | | | | | | | | | | | | | | | () | | | () | | | () | |
Settlement/curtailment losses/(gains) (a) | | | | | | | | | | | | | | | | () | | | | | | () | | | | |
| Special termination benefits | () | | | | | | | | | | | | | | | | | | | | | | | | | |
| Total other pension and retiree medical benefits (income)/expense | $ | () | | | $ | | | | $ | () | | | $ | () | | | $ | () | | | $ | () | | | $ | () | | | $ | () | | | $ | () | |
| Total | $ | | | | $ | | | | $ | | | | $ | | | | $ | () | | | $ | | | | $ | | | | $ | | | | $ | | |
million ($ million after-tax or $ per share) related to lump sum distributions exceeding the total of annual service and interest cost.
% | | | % | | | % | | | % | | | % | | | % | | | % | | | % | | | % | Interest cost discount rate (a) | | % | | | % | | | % | | | % | | | % | | | % | | | % | | | % | | | % |
Expected return on plan assets (a) | | % | | | % | | | % | | | % | | | % | | | % | | | % | | | % | | | % |
| Rate of salary increases | | % | | | % | | | % | | | % | | | % | | | % | | | | | | |
| | | | | | | | | | | | | | | | | |
| Projected Benefit Obligation | | | | | | | | | | | | | | | | | |
| Discount rate | | % | | | % | | | % | | | % | | | % | | | % | | | % | | | % | | | % |
| Rate of salary increases | | % | | | % | | | % | | | % | | | % | | | % | | | | | | |
(a)2022 U.S. rates reflect remeasurement of a U.S. qualified defined benefit pension plan in the second quarter of 2022.
) | | $ | () | | | $ | () | | | $ | () | | | | | | | Fair value of plan assets | $ | | | | $ | | | | $ | | | | $ | | | | | | |
Selected information for plans with projected benefit obligation in excess of plan assets | | | | | | |
| Benefit obligation | $ | () | | | $ | () | | | $ | () | | | $ | () | | | $ | () | | | $ | () | |
| Fair value of plan assets | $ | | | | $ | | | | $ | | | | $ | | | | $ | | | | $ | | |
Of the total projected pension benefit obligation as of December 30, 2023, approximately $ million relates to plans that we do not fund because the funding of such plans does not receive favorable tax treatment.
Future Benefit Payments
| | $ | | | | $ | | | | $ | | | | $ | | | | $ | | | Retiree medical (a) | $ | | | | $ | | | | $ | | | | $ | | | | $ | | | | $ | | |
(a)Expected future benefit payments for our retiree medical plans do not reflect any estimated subsidies expected to be received under the 2003 Medicare Act. Subsidies are expected to be approximately $ million for each of the years from 2024 through 2028 and approximately $ million in total for 2029 through 2033.
These future benefit payments to beneficiaries include payments from both funded and unfunded plans.
| | $ | | | | $ | | | | $ | | | | $ | | | | $ | | | | Non-discretionary | | | | | | | | | | | | | | | | | |
| Total | $ | | | | $ | | | | $ | | | | $ | | | | $ | | | | $ | | |
(a)Includes $ million contribution in 2023, $ million contribution in 2022 and $ million contribution in 2021 to fund our U.S. qualified defined benefit plans.
We made a discretionary contribution of $ to a U.S. qualified defined benefit plan in January 2024. In addition, in 2024, we expect to make non-discretionary contributions of approximately $ million to our U.S. and international pension benefit plans and contributions of approximately $ million for retiree medical benefits.
We also regularly evaluate opportunities to reduce risk and volatility associated with our pension and retiree medical plans.
Plan Assets
Our pension plan investment strategy includes the use of actively managed accounts and is reviewed periodically in conjunction with plan obligations, an evaluation of market conditions, tolerance for risk and cash requirements for benefit payments. This strategy is also applicable to funds held for the retiree medical plans. Our investment objective includes ensuring that funds are available to meet the plans’ benefit obligations when they become due. Assets contributed to our pension plans are no longer controlled by us, but become the property of our individual pension plans. However, we are indirectly impacted by changes in these plan assets as compared to changes in our projected obligations. Our overall investment policy is to prudently invest plan assets in a well-diversified portfolio of equity and high-quality debt securities and real estate to achieve our long-term return expectations. Our investment policy also permits the use of derivative instruments, such as futures and forward contracts, to reduce interest rate and foreign currency risks. Futures contracts represent commitments to purchase or sell securities at a future date and at a specified price. Forward contracts consist of currency forwards.
%. Our target investment allocations for U.S. plan assets are as follows: | | | | | | | | | | | |
| 2024 | | 2023 |
| Fixed income | | % | | | % |
| U.S. equity | | % | | | % |
| International equity | | % | | | % |
| Real estate | | % | | | % |
Actual investment allocations may vary from our target investment allocations due to prevailing market conditions. We regularly review our actual investment allocations and periodically rebalance our investments.
The expected return on plan assets is based on our investment strategy and our expectations for long-term rates of return by asset class, taking into account volatility and correlation among asset classes and our historical experience. We also review current levels of interest rates and inflation to assess the reasonableness of the long-term rates. We evaluate our expected return assumptions annually to ensure that they are reasonable. To calculate the expected return on plan assets, our market-related value of assets for fixed income is the actual fair value. For all other asset categories, such as equity securities, we use a
| | $ | | | Government securities (c) | 2 | | | | | | |
Corporate bonds (c) | 2 | | | | | | |
Mortgage-backed securities (c) | 2 | | | | | | |
Contracts with insurance companies (d) | 3 | | | | | | |
Cash and cash equivalents (e) | 1, 2 | | | | | | |
| Sub-total U.S. plan assets | | | | | | | |
Real estate commingled funds measured at net asset value (f) | | | | | | | |
Dividends and interest receivable, net of payables | | | | | | | |
| Total U.S. plan assets | | | $ | | | | $ | | |
| International plan assets | | | | | |
Equity securities (b) | 1 | | $ | | | | $ | | |
Government securities (c) | 2 | | | | | | |
Corporate bonds (c) | 2 | | | | | | |
Fixed income commingled funds (g) | 1 | | | | | | |
Contracts with insurance companies (d) | 3 | | | | | | |
| Cash and cash equivalents | 1 | | | | | | |
| Sub-total international plan assets | | | | | | | |
Real estate commingled funds measured at net asset value (f) | | | | | | | |
| Dividends and interest receivable | | | | | | | |
| Total international plan assets | | | $ | | | | $ | | |
(a)Includes $ million and $ million in 2023 and 2022, respectively, of retiree medical plan assets that are restricted for purposes of providing health benefits for U.S. retirees and their beneficiaries.
(b)Invested in U.S. and international common stock and commingled funds, and the preferred stock portfolio was invested in domestic and international corporate preferred stock investments. The common and preferred stock investments are based on quoted prices in active markets. The commingled funds are based on the published price of the fund and include one large-cap fund that represents % and % of total U.S. plan assets for 2023 and 2022, respectively.
(c)These investments are based on quoted bid prices for comparable securities in the marketplace and broker/dealer quotes in active markets. Corporate bonds of U.S.-based companies represents % and % of total U.S. plan assets for 2023 and 2022, respectively.
(d)Based on the fair value of the contracts as determined by the insurance companies using inputs that are not observable. The changes in Level 3 amounts were not significant in the years ended December 30, 2023 and December 31, 2022.
(e)Includes Level 1 assets of $ million for 2023 and Level 2 assets of $ million and $ million for 2023 and 2022, respectively.
(f)The real estate commingled funds include investments in limited partnerships. These funds are based on the net asset value of the appraised value of investments owned by these funds as determined by independent third parties using inputs that are not observable. The majority of the funds are redeemable quarterly subject to availability of cash and have notice periods ranging from to days.
(g)Based on the published price of the fund.
% | | | % | | Ultimate projected increase | | % | | | % |
Year of ultimate projected increase | | | |
Annually, we review external data and our historical experience to estimate assumed health care cost trend rates that impact our retiree medical plan obligation and expense, however the cap on our share of retiree medical costs limits the impact.
Savings Plan
Certain U.S. employees are eligible to participate in a 401(k) savings plan, which is a voluntary defined contribution plan. The plan is designed to help employees accumulate savings for retirement and we make Company matching contributions for certain employees on a portion of employee contributions based on years of service.
Certain U.S. employees, who are either not eligible to participate in a defined benefit pension plan or whose benefit is capped, are also eligible to receive an employer contribution based on either years of service or age and years of service regardless of employee contribution.
In 2023, 2022 and 2021, our total Company contributions were $ million, $ million and $ million, respectively.
Note 8 —
| | $ | | | Commercial paper (%) | | | | | |
Other borrowings (% and %) | | | | | |
| $ | | | | $ | | |
Long-term debt obligations (b) | | | |
|
|
|
|
|
|
|
|
|
|
|
|
(a)Excludes debt issuance costs, discounts and premiums.
The net proceeds from the issuances of the above notes will be used for general corporate purposes, including the repayment of commercial paper.
In 2023, we entered into a new five-year unsecured revolving credit agreement (Five-Year Credit Agreement), which expires on May 26, 2028. The Five-Year Credit Agreement enables us and our borrowing subsidiaries to borrow up to $ billion in U.S. dollars and/or euros, including a $ billion swing line subfacility for euro-denominated borrowings permitted to be borrowed on a same-day basis, subject to customary terms and conditions. We may request that commitments under this agreement be increased up to $ billion (or the equivalent amount in euros). Additionally, we may, once a year, request renewal of the agreement for an additional one-year period. The Five-Year Credit Agreement replaced our $ billion five-year credit agreement, dated as of May 27, 2022.
Also in 2023, we entered into a new 364-day unsecured revolving credit agreement (364-Day Credit Agreement), which expires on May 24, 2024. The 364-Day Credit Agreement enables us and our borrowing subsidiaries to borrow up to $ billion in U.S. dollars and/or euros, subject to customary terms and conditions. We may request that commitments under this agreement be increased up to $ billion (or the equivalent amount in euros). We may request renewal of this facility for an additional 364-day period or convert any amounts outstanding into a term loan for a period of up to one year, which term loan would mature no later than the anniversary of the then effective termination date. The 364-Day Credit Agreement replaced our $ billion 364-day credit agreement, dated as of May 27, 2022.
Funds borrowed under the Five-Year Credit Agreement and the 364-Day Credit Agreement may be used for general corporate purposes. Subject to certain conditions, we may borrow, prepay and reborrow amounts under these agreements. As of December 30, 2023, there were outstanding borrowings under the Five-Year Credit Agreement or the 364-Day Credit Agreement.
In 2023, we discharged via legal defeasance $ million outstanding principal amount of certain notes originally issued by our subsidiary, The Quaker Oats Company, following the deposit of $ million of U.S. government securities with the Bank of New York Mellon, as trustee, in the fourth quarter of 2022.
In 2022, we paid $ million to redeem all $ million outstanding principal amount of our % senior notes due May 2022, we paid $ million to redeem all $ million outstanding principal amount of our % senior notes due July 2022 and we paid $ million to redeem all $ million outstanding
% senior notes due March 2029 and % notes due May 2035.In 2021, we completed cash tender offers to redeem $ billion principal amount of certain notes, with maturity dates ranging from May 2035 to March 2060 and interest rates ranging from % to %, for $ billion in cash. As a result of the cash tender offers, we recorded a pre-tax charge of $ million ($ million after-tax or $ per share) to net interest expense and other, primarily representing the tender price paid over the carrying value of the tendered notes and loss on treasury rate locks used to mitigate the interest rate risk on the cash tender offers.
Also in 2021, we paid $ million to redeem all $ million outstanding principal amount of our % senior notes due 2021 and terminated the associated interest rate swap with a notional amount of $ million.
Note 9 —
such gains or losses reclassified during the year ended December 30, 2023. Cash flows from derivatives used to manage commodity price, foreign exchange or interest rate risks are classified as operating activities in the cash flow statement. We classify both the earnings and cash flow impact from these derivatives consistent with the underlying hedged item.
Credit Risk
We perform assessments of our counterparty credit risk regularly, including reviewing netting agreements, if any, and a review of credit ratings, credit default swap rates and potential nonperformance of the counterparty. Based on our most recent assessment of our counterparty credit risk, we consider this risk to be low. In addition, we enter into derivative contracts with a variety of financial institutions that we believe are creditworthy in order to reduce our concentration of credit risk.
million. We have posted collateral under these contracts and credit-risk-related contingent features were triggered as of December 30, 2023.Commodity Prices
We are subject to commodity price risk because our ability to recover increased costs through higher pricing may be limited in the competitive environment in which we operate. This risk is managed through the use of fixed-price contracts and purchase orders, pricing agreements and derivative instruments, which primarily include swaps and futures. In addition, risk to our supply of certain raw materials is mitigated through purchases from multiple geographies and suppliers. We use derivatives, with terms of no more than , to hedge price fluctuations related to a portion of our anticipated commodity purchases, primarily for agricultural products, energy and metals. Derivatives used to hedge commodity price risk that do not qualify for hedge accounting treatment are marked to market each period with the resulting gains and losses recorded in corporate unallocated expenses as either cost of sales or selling, general and administrative expenses, depending on the underlying commodity. These gains and losses are subsequently reflected in division results when the divisions recognize the cost of the underlying commodity in operating profit.
Our commodity derivatives had a total notional value of $ billion as of December 30, 2023 and $ billion as of December 31, 2022.
Foreign Exchange
We are exposed to foreign exchange risks in the international markets in which our products are made, manufactured, distributed or sold. Additionally, we are exposed to foreign exchange risk from net investments in foreign subsidiaries, foreign currency purchases and foreign currency assets and liabilities created in the normal course of business. We manage this risk through sourcing purchases from local suppliers, negotiating contracts in local currencies with foreign suppliers and through the use of derivatives, primarily forward contracts with terms of no more than . Exchange rate gains or losses related to foreign currency transactions are recognized as transaction gains or losses on our income statement as incurred. We also use net investment hedges to partially offset the effects of foreign currency on our investments in certain of our foreign subsidiaries.
Our foreign currency derivatives had a total notional value of $ billion as of December 30, 2023 and $ billion as of December 31, 2022. The total notional amount of our debt instruments designated as net investment hedges was $ billion as of December 30, 2023 and $ billion as of December 31, 2022. For foreign currency derivatives that do not qualify for hedge accounting treatment, gains and losses were offset by changes in the underlying hedged items, resulting in no material net impact on earnings.
Interest Rates
We centrally manage our debt and investment portfolios considering investment opportunities and risks, tax consequences and overall financing strategies. We use various interest rate derivative instruments including, but not limited to, interest rate swaps, cross-currency interest rate swaps, Treasury locks and swap locks to manage our overall interest expense and foreign exchange risk. These instruments effectively change the interest rate and currency of specific debt issuances. The notional amount, interest payment and maturity date of our cross-currency interest rate swaps match the principal, interest payment and maturity date of the related debt. Our cross-currency interest rate swaps have terms of no more than
. Our Treasury locks and swap locks are entered into to protect against unfavorable interest rate changes relating to forecasted debt transactions.Our interest rate derivatives had a total notional value of $ billion as of December 30, 2023 and December 31, 2022.
As of December 30, 2023, approximately % of total debt was subject to variable rates, compared to approximately %, after the impact of the related interest rate derivative instruments, as of December 31, 2022.
Debt Securities
Held-to-Maturity
Investments in debt securities that we have the positive intent and ability to hold until maturity are classified as held-to-maturity. Highly liquid debt securities with original maturities of three months or less are recorded as cash equivalents. Our held-to-maturity debt securities consist of commercial paper. As of December 30, 2023, we had $ million of investments in commercial paper recorded in cash and cash equivalents. As of December 31, 2022, we had investments in held-to-maturity debt securities. Held-to-maturity debt securities are recorded at amortized cost, which approximates fair value, and realized gains or losses are reported in earnings. As of December 30, 2023, gross unrecognized gains and losses and the allowance for expected credit losses were .
Available-for-Sale
Investments in available-for-sale debt securities are reported at fair value. Changes in the fair value of available-for-sale debt securities are generally recognized in accumulated other comprehensive loss within common shareholders’ equity. Changes in the fair value of available-for-sale debt securities impact earnings only when such securities are sold, or an allowance for expected credit losses or impairment is recognized. We regularly evaluate our investment portfolio for expected credit losses and impairment. In making this judgment, we evaluate, among other things, the extent to which the fair value of a debt security is less than its amortized cost; the financial condition of the issuer, including the credit quality, and any changes thereto; and our intent to sell, or whether we will more likely than not be required to sell, the debt security before recovery of its amortized cost basis. Our assessment of whether a debt security has a credit loss or is impaired could change in the future due to new developments or changes in assumptions related to any particular debt security.
In 2022, we entered into an agreement with Celsius to distribute Celsius energy drinks in the United States (see Note 4 for further information) and invested $ million in Series A convertible preferred shares issued by Celsius, which included certain conversion and redemption features. The preferred shares automatically convert into Celsius common shares after years if certain market-based conditions are met, or can be redeemed after years. Shares underlying the transaction were priced at $ per share, and the preferred shares are entitled to a % annual dividend, payable either in cash or in-kind. Given our redemption right, we classified our investment in the convertible preferred stock as an available-for-sale debt security. As of December 31, 2022, the fair value of this investment was classified as Level 2, based primarily on the transaction price. There were unrealized gains and losses on our investment in the year ended December 31, 2022. In the year ended December 30, 2023, we transferred $ million from Level 2 to Level 3 as unobservable inputs to the fair value became more significant and subsequently recorded an unrealized gain of $ million in other comprehensive income and a decrease in the investment of $ million due to cash dividends received. There were impairment charges related to our investment in the years ended December 30, 2023 and December 31, 2022.
% noncontrolling interest in TBG, operating across North America and Europe. We have significant influence over our investment in TBG and account for our investment under the equity method, recognizing our proportionate share of TBG’s earnings on our income statement (recorded in selling, general and administrative expenses). See Note 13 for further information.In 2023, we recorded our proportionate share of TBG’s earnings, which includes an impairment of TBG’s indefinite-lived intangible assets, and recorded an other-than-temporary impairment of our investment, both of which resulted in pre-tax impairment charges of $ million ($ million after-tax or $ per share), recorded in selling, general and administrative expenses in our PBNA division. We estimated the fair value of our ownership in TBG using discounted cash flows and an option pricing model related to our liquidation preference in TBG, which we categorized as Level 3 (significant unobservable inputs) in the fair value hierarchy.
Recurring Fair Value Measurements
| | $ | | | | $ | | | | $ | | |
Index funds (c) | 1 | | $ | | | | $ | | | | $ | | | | $ | | |
Prepaid forward contracts (d) | 2 | | $ | | | | $ | | | | $ | | | | $ | | |
Deferred compensation (e) | 2 | | $ | | | | $ | | | | $ | | | | $ | | |
| | |
| | |
| | |
Derivatives designated as cash flow hedging instruments: | | | | | | | | | |
Foreign exchange (f) | 2 | | $ | | | | $ | | | | $ | | | | $ | | |
Interest rate (f) | 2 | | | | | | | | | | | | |
| | |
Commodity (g) | 2 | | | | | | | | | | | | |
| | | $ | | | | $ | | | | $ | | | | $ | | |
Derivatives not designated as hedging instruments: | | | | | | | | | |
Foreign exchange (f) | 2 | | $ | | | | $ | | | | $ | | | | $ | | |
| | |
|
)
|
| 2023 | | 2022 |
| Cost of Sales | | Selling, general and administrative expenses | | Total | | Cost of Sales | | Selling, general and administrative expenses | | Total |
| Foreign exchange | $ | () | | | $ | | | | $ | | | | $ | | | | $ | () | | | $ | () | |
| Commodity | | | | | | | | | | () | | | () | | | () | |
| Total | $ | | | | $ | | | | $ | | | | $ | () | | | $ | () | | | $ | () | |
Note 10 —
| | | | $ | | | | | | $ | | | | | Net income available for PepsiCo common shareholders | $ | | | | | | | $ | | | | | | | $ | | | | | |
| Dilutive securities: | | | | | | | | | | | |
Stock options, RSUs, PSUs and other (b) | | | | | | | | | | | | | | | | | |
| | | | |
Diluted | $ | | | | | | | $ | | | | | | | $ | | | | | |
Diluted net income attributable to PepsiCo per common share | $ | | | | | | $ | | | | | | $ | | | | |
(a)Weighted-average common shares outstanding (in millions).
(b)The dilutive effect of these securities is calculated using the treasury stock method.
million for the year ended December 30, 2023 and immaterial for the years ended December 31, 2022 and December 25, 2021.
Note 11 —
) | | $ | | | | $ | () | | | $ | () | | | $ | () | | Other comprehensive (loss)/income before reclassifications (c) | () | | | | | | | | | | | | | |
| Amounts reclassified from accumulated other comprehensive loss | | | | () | | | | | | | | | | |
| Net other comprehensive (loss)/income | () | | | | | | | | | | | | | |
| Tax amounts | () | | | () | | | () | | | | | | () | |
Balance as of December 25, 2021 (b) | () | | | | | | () | | | | | | () | |
Other comprehensive (loss)/income before reclassifications (d) | () | | | () | | | | | | | | | () | |
| Amounts reclassified from accumulated other comprehensive loss | | | | () | | | | | | | | | | |
| Net other comprehensive (loss)/income | () | | | () | | | | | | | | | () | |
| Tax amounts | () | | | | | | () | | | () | | | () | |
Balance as of December 31, 2022 (b) | () | | | | | | () | | | | | | () | |
Other comprehensive (loss)/income before reclassifications (e) | () | | | () | | | () | | | | | | () | |
| Amounts reclassified from accumulated other comprehensive loss | | | | | | | | | | | | | | |
| Net other comprehensive (loss)/income | () | | Ye | () | | | () | | | | | | () | |
| Tax amounts | | | | | | | | | | () | | | () | |
Balance as of December 30, 2023 (b) | $ | () | | | $ | () | | | $ | () | | | $ | | | | $ | () | |
(a)The changes primarily represent fair value increases in available-for-sale debt securities, including our investment in Celsius convertible preferred stock in 2023. See Note 9 for further information.
(b)Pension and retiree medical amounts are net of taxes of $ million as of December 26, 2020, $ million as of December 25, 2021, $ million as of December 31, 2022 and $ million as of December 30, 2023.
(c)Currency translation adjustment primarily reflects depreciation of the Turkish lira, Swiss franc and Mexican peso.
(d)Currency translation adjustment primarily reflects depreciation of the Egyptian pound and British pound sterling.
(e)Currency translation adjustment primarily reflects depreciation of the Russian ruble and South African rand, partially offset by the appreciation of the Mexican peso.
| | $ | | | | $ | | | | Selling, general and administrative expenses | | | | | | | | |
| Cash flow hedges: | | | | | | | |
| Foreign exchange contracts | $ | () | | | $ | () | | | $ | | | | Net revenue |
| Foreign exchange contracts | | | | () | | | | | | Cost of sales |
| Interest rate derivatives | () | | | | | | | | | Selling, general and administrative expenses |
| Commodity contracts | | | | () | | | () | | | Cost of sales |
| Commodity contracts | () | | | () | | | () | | | Selling, general and administrative expenses |
| Net losses/(gains) before tax | | | | () | | | () | | | |
| Tax amounts | () | | | | | | | | | |
| Net losses/(gains) after tax | $ | | | | $ | () | | | $ | () | | | |
| | | | | | | |
| Pension and retiree medical items: | | | | | | | |
| Amortization of net prior service credit | $ | () | | | $ | () | | | $ | () | | | Other pension and retiree medical benefits income |
| Amortization of net losses | | | | | | | | | | Other pension and retiree medical benefits income |
| Settlement/curtailment losses | | | | | | | | | | Other pension and retiree medical benefits income |
| Net losses before tax | | | | | | | | | | |
| Tax amounts | () | | | () | | | () | | | |
| Net losses after tax | $ | | | | $ | | | | $ | | | | |
| | | | | | | |
|
|
|
|
|
| Total net losses reclassified for the year, net of tax | $ | | | | $ | | | | $ | | | | |
Note 12 —
years, some of which include options to extend the lease term for up to and some of which include options to terminate the lease within . We consider these options in determining the lease term used to establish our right-of-use assets and lease liabilities. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants.As most of our leases do not provide an implicit rate, we use our incremental borrowing rate based on the information available at commencement date in determining the present value of lease payments.
We have lease agreements that contain both lease and non-lease components. For real estate leases, we account for lease components together with non-lease components (e.g., common-area maintenance).
| | $ | | | | $ | | | Variable lease cost (b) | $ | | | | $ | | | | $ | | |
Short-term lease cost (c) | $ | | | | $ | | | | $ | | |
(a)Includes right-of-use asset amortization of $ million, $ million, and $ million in 2023, 2022, and 2021, respectively.
(b)Primarily related to adjustments for inflation, common-area maintenance and property tax.
(c)Not recorded on our balance sheet.
In 2023, 2022 and 2021, we recognized gains of $ million, $ million and $ million, respectively, on sale-leaseback transactions with terms under five years.
| | $ | | | | $ | | | | Non-cash activity: | | | | | |
Right-of-use assets obtained in exchange for lease obligations | $ | | | | $ | | | | $ | | |
| | $ | | | Current lease liabilities | | Accounts payable and other current liabilities | | $ | | | | $ | | |
Non-current lease liabilities | | Other liabilities | | $ | | | | $ | | |
years | years | | years | | Weighted-average discount rate | | % | | | % | | | % |
| | 2025 | | |
| 2026 | | |
| 2027 | | |
| 2028 | | |
| 2029 and beyond | | |
| Total lease payments | | |
| Less: Imputed interest | | |
| Present value of lease liabilities | $ | | |
Finance leases were not material as of December 30, 2023, December 31, 2022 and December 25, 2021.
Lessor
We have various arrangements for certain foodservice and vending equipment under which we are the lessor. These leases meet the criteria for operating lease classification. Lease income associated with these leases is not material.
Note 13 —
Juice Transaction
In the first quarter of 2022, we sold our Tropicana, Naked and other select juice brands to PAI Partners for approximately $ billion in cash, subject to purchase price adjustments, and a % noncontrolling interest in TBG, operating across North America and Europe. The North America portion of the transaction was completed on January 24, 2022 and the Europe portion of the transaction was completed on February 1, 2022. In the United States, PepsiCo acts as the exclusive distributor for TBG’s portfolio of brands for small-format and foodservice customers with chilled DSD. We have significant influence over our investment in TBG and account for our investment under the equity method, recognizing our proportionate share of TBG’s earnings on our income statement (recorded in selling, general and administrative expenses).
As a result of this transaction, in the year ended December 31, 2022, we recorded a gain in our PBNA and Europe divisions (see detailed income statement activity below), including $ million related to the remeasurement of our % ownership in TBG at fair value using a combination of the transaction price, discounted cash flows and an option pricing model related to our liquidation preference in TBG. In the fourth quarter of 2022, we reached an agreement on final purchase price adjustments for net working capital and net debt amounts as of the transaction close date compared to targeted amounts set forth in the purchase agreement.
A summary of income statement activity related to the Juice Transaction for the year ended December 31, 2022 is as follows:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| PBNA | | Europe | | Corporate | | Total PepsiCo | | Provision for income taxes(a) | | Net income attributable to PepsiCo | | Impact on net income attributable to PepsiCo per common share | |
| Gain associated with the Juice Transaction | $ | () | | | $ | () | | | $ | | | | $ | () | | | $ | | | | $ | () | | | $ | | | |
| Acquisition and divestiture-related charges | | | | | | | | | | | | | () | | | | | | () | | |
| Operating profit | $ | () | | | $ | () | | | $ | | | | () | | | | | | () | | | | | |
Other pension and retiree medical benefits income (b) | | | | | | | () | | | | | | () | | | | | |
| Total Juice Transaction | | | | | | | $ | () | | | $ | | | | $ | () | | | $ | | | (c) |
(a)Includes $ million of deferred tax expense related to the recognition of our investment in TBG.
(b)Includes $ million curtailment gain, partially offset by $ million special termination benefits.
(c)Does not sum due to rounding.
In connection with the sale, we entered into a transition services agreement with PAI Partners, under which we provide certain services to TBG to help facilitate an orderly transition of the business following the sale. In return for these services, TBG is required to pay certain agreed upon fees to reimburse us for our costs without markup.
The Juice Transaction did not meet the criteria to be classified as discontinued operations. As of December 30, 2023 and December 31, 2022, there were amounts classified as held for sale.
In the year ended December 30, 2023, we recognized impairment charges related to our TBG investment. See Notes 1 and 9 for further information.
| | $ | | | | $ | | | | PBNA | | | | | | | | |
Europe (a) | () | | | | | | | |
| AMESA | | | | | | | | |
| APAC | | | | | | | | |
Corporate (b) | | | | | | | () | |
Total (c) | | | | | | | () | |
| Other pension and retiree medical benefits expense | | | | | | | | |
| Total acquisition and divestiture-related charges | $ | | | | $ | | | | $ | () | |
After-tax amount (d) | $ | | | | $ | | | | $ | () | |
| Impact on net income attributable to PepsiCo per common share | $ | () | | | $ | () | | | $ | | |
|
(a)Income amount represents adjustments for changes in estimates of previously recorded amounts.
(b)Income amount primarily relates to the acceleration payment made in the fourth quarter of 2021 under the contingent consideration arrangement associated with our acquisition of Rockstar, which is partially offset by divestiture-related charges associated with the Juice Transaction.
(c)Primarily recorded in selling, general and administrative expenses.
(d)The amount in 2021 includes a tax benefit related to contributions to socioeconomic programs in South Africa.
Note 14 —
billion of our accounts payable are to suppliers participating in these financing arrangements.
Note 15 —
| | $ | | | | |
| Other receivables | | | | | | | | | |
| Total | | | | | | | | | |
| Allowance, beginning of year | | | | | | | | | $ | | |
Net amounts charged to expense (b) | | | | | | | | | () | |
Deductions (c) | | | () | | | () | | | () | |
Other (d) | | | () | | | () | | | () | |
| Allowance, end of year | | | | | | | | | $ | | |
| Accounts and notes receivable, net | | | $ | | | | $ | | | | |
| | | | | | | |
|
|
|
|
|
|
| Property, plant and equipment, net | Average Useful Life (Years) | | | | | | |
| Land | | | $ | | | | $ | | | | |
| Buildings and improvements | - | | | | | | | | |
| Machinery and equipment, including fleet and software | - | | | | | | | | |
| Construction in progress | | | | | | | | | |
| | | | | | | | | |
| Accumulated depreciation | | | () | | | () | | | |
Property, plant and equipment, net (e) | | | $ | | | | $ | | | | |
| Depreciation expense | | | $ | | | | $ | | | | $ | | |
| | | | | | | |
| Other assets | | | | | | | |
| Noncurrent notes and accounts receivable | | | $ | | | | $ | | | | |
| Deferred marketplace spending | | | | | | | | | |
Pension plans (f) | | | | | | | | | |
Right-of-use assets (g) | | | | | | | | | |
Other investments (h) | | | | | | | | | |
| Other | | | | | | | | | |
| Total | | | $ | | | | $ | | | | |
| | | | | | | |
|
|
| Accounts payable and other current liabilities | | | | | | | |
Accounts payable (i) | | | $ | | | | $ | | | | |
| Accrued marketplace spending | | | | | | | | | |
| Accrued compensation and benefits | | | | | | | | | |
| Dividends payable | | | | | | | | | |
Current lease liabilities (g) | | | | | | | | | |
Other current liabilities (j) | | | | | | | | | |
| Total | | | $ | | | | $ | | | | |
(a)Increase primarily reflects strong revenue performance across much of our portfolio in 2023.
(b)2021 includes reductions in allowance for expected credit losses related to COVID-19 pandemic recorded in 2020.
(c)Includes accounts written off.
(d)Includes adjustments related primarily to currency translation and other adjustments.
(e)Change is driven by increase in capital spending, partially offset by depreciation.
(f)See Note 7 for further information.
(g)See Note 12 for further information.
(h)Increase in 2023 primarily reflects unrealized pre-tax gains on our investment in Celsius convertible preferred stock. See Note 9 for further information.
(i)Increase reflects higher capital expenditures and commodity costs in 2023.
(j)Increase primarily reflects change in income tax provision. See Note 5 for further information.
| | $ | | | | $ | | | Income taxes paid, net of refunds (b) | $ | | | | $ | | | | $ | | |
(a)2022 excludes the premiums paid in accordance with the debt transactions. 2021 excludes the charge related to cash tender offers. See Note 8 for further information.
(b)In each of 2023, 2022 and 2021, includes tax payments of $ million related to the TCJ Act.
Supplemental Non-Cash Activity
| | | | | | | | | | | | | | | | | |
| 2023 | | 2022 | | 2021 |
| Debt discharged via legal defeasance | $ | | | | $ | | | | $ | | |
|
The following table provides a reconciliation of cash and cash equivalents and restricted cash as reported within the balance sheet to the same items as reported in the cash flow statement:
| | | | | | | | | | | |
| 2023 | | 2022 |
| Cash and cash equivalents | $ | | | | $ | | |
|
Restricted cash included in other assets (a) | | | | | |
| Total cash and cash equivalents and restricted cash | $ | | | | $ | | |
(a)Primarily relates to collateral posted against certain of our derivative positions.
Report of Independent Registered Public Accounting Firm
To the Shareholders and Board of Directors
PepsiCo, Inc.:
Opinions on the Consolidated Financial Statements and Internal Control Over Financial Reporting
We have audited the accompanying Consolidated Balance Sheet of PepsiCo, Inc. and Subsidiaries (the Company) as of December 30, 2023 and December 31, 2022, the related Consolidated Statements of Income, Comprehensive Income, Cash Flows, and Equity for each of the fiscal years in the three-year period ended December 30, 2023, and the related notes (collectively, the consolidated financial statements). We also have audited the Company’s internal control over financial reporting as of December 30, 2023, based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 30, 2023 and December 31, 2022, and the results of its operations and its cash flows for each of the fiscal years in the three-year period ended December 30, 2023, in conformity with U.S. generally accepted accounting principles. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 30, 2023 based on criteria established in Internal Control – Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.
Basis for Opinions
The Company’s management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Annual Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company’s consolidated financial statements and an opinion on the Company’s internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.
Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.
Definition and Limitations of Internal Control Over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Critical Audit Matters
The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.
Sales incentive accruals
As discussed in Note 2 to the consolidated financial statements, the Company offers sales incentives and discounts through various programs to customers and consumers. A number of the sales incentives are based on annual targets, resulting in the need to accrue for the expected liability. These incentives are accrued for in the “Accounts payable and other current liabilities” line on the balance sheet. These accruals are based on sales incentive agreements, expectations regarding customer and consumer participation and performance levels, and historical experience and trends.
We identified the evaluation of certain of the Company’s sales incentive accruals as a critical audit matter. Subjective and complex auditor judgment is required in evaluating these sales incentive accruals as a result of the timing difference between when the product is delivered and when the incentive is settled. This specifically related to (1) forecasted customer and consumer participation and performance level assumptions underlying the accrual, and (2) the impact of historical experience and trends.
The following are the primary procedures we performed to address this critical audit matter. We evaluated the design and tested the operating effectiveness of certain internal controls related to the sales incentive process, including controls related to (1) the accrual methodology, (2) assumptions around forecasted customer and consumer participation, (3) performance levels, and (4) monitoring of actual sales incentives incurred compared to estimated sales incentives in respect of historical periods. To evaluate the timing and amount of certain accrued sales incentives we (1) analyzed the accrual by sales incentive type as compared to historical trends to identify specific sales incentives that may require additional testing, (2) recalculated expenses and closing accruals on a sample basis,
based on volumes sold and terms of the sales incentives, (3) assessed the Company’s ability to accurately estimate its sales incentive accrual by comparing previously established accruals to actual settlements, and (4) tested a sample of settlements or claims that occurred after period end, and compared them to the recorded sales incentive accrual.
Carrying value of certain reacquired and acquired franchise rights and SodaStream goodwill
As discussed in Notes 2 and 4 to the consolidated financial statements, the Company performs impairment testing of its goodwill and other indefinite-lived intangible assets on an annual basis during the third quarter of each fiscal year or more frequently if events or changes in circumstances indicate that it is more likely than not that an impairment exists. The carrying value of other indefinite-lived intangible assets as of December 30, 2023 was $13.7 billion, which represents 13.7% of total assets, and includes certain PepsiCo Beverages North America’s (PBNA) reacquired and acquired franchise rights, which had a carrying value of $8.7 billion as of December 30, 2023. The carrying value of goodwill as of December 30, 2023 was $17.7 billion, which represents 17.6% of total assets, and includes goodwill related to the SodaStream reporting unit in Europe.
We identified the assessment of the carrying value of PBNA’s reacquired and acquired franchise rights and SodaStream goodwill in Europe as a critical audit matter. The impairment analysis of these indefinite-lived intangible assets required significant auditor judgment to evaluate the Company’s forecasted revenue and profitability levels, including the expected long-term growth rates and the selection of the discount rates to be applied to the projected cash flows. Significant auditor judgment was necessary to assess the subjective and uncertain impact of competitive operating and macroeconomic factors on future levels of revenue, operating profit and cash flows.
The following are the primary procedures we performed to address this critical audit matter. We evaluated the design and tested the operating effectiveness of certain internal controls related to the goodwill and other indefinite-lived intangible assets impairment process, including controls related to the development of forecasted revenue, profitability levels, expected long-term growth rates, and selection of the discount rates to be applied to the projected cash flows used to estimate the fair value of the goodwill and other indefinite-lived intangible assets. We also evaluated the sensitivity of the Company’s conclusion related to changes in assumptions, including the assessment of changes in assumptions from prior periods. To assess the Company’s ability to accurately forecast, we compared the Company’s historical forecasted results to actual results. We compared forecasted revenue and profitability levels in the cash flow projections used in the impairment tests with available external industry data and other internal information. We involved valuation professionals with specialized skills and knowledge, who assisted in evaluating (1) the long-term growth rates used in the impairment tests by comparing against economic data and information specific to the respective assets, including projected long-term nominal Gross Domestic Product growth in the respective local countries, and (2) the discount rates used in the impairment tests by comparing them against discount rates that were independently developed using publicly available market data, including that of comparable companies.
Unrecognized tax benefits
As discussed in Note 5 to the consolidated financial statements, the Company’s global operating model gives rise to income tax obligations in the United States and in certain foreign jurisdictions in which it operates. As of December 30, 2023, the Company recorded reserves for unrecognized tax benefits of $2.1 billion. The Company establishes reserves if it believes that certain positions taken in its tax returns are subject to challenge and the Company likely will not succeed, even though the Company believes the tax return position is supportable under the tax law. The Company adjusts
these reserves, as well as the related interest, in light of new information, such as the progress of a tax examination, new tax law, relevant court rulings or tax authority settlements.
We identified the evaluation of certain of the Company’s unrecognized tax benefits as a critical audit matter because the application of tax law and interpretation of a tax authority’s settlement history is complex and involves subjective judgment. Such judgments impact both the timing and amount of the reserves that are recognized, including judgments about re-measuring liabilities for positions taken in prior years’ tax returns in light of new information.
The following are the primary procedures we performed to address this critical audit matter. We evaluated the design and tested the operating effectiveness of certain internal controls related to the unrecognized tax benefits process, including controls to (1) identify uncertain income tax positions, (2) evaluate the tax law and tax authority’s settlement history used to estimate the unrecognized tax benefits, and (3) monitor for new information that may give rise to changes to the existing unrecognized tax benefits, such as progress of a tax examination, new tax law or tax authority settlements. We involved tax and valuation professionals with specialized skills and knowledge, who assisted in assessing the unrecognized tax benefits by (1) evaluating the Company’s tax structure and transactions, including transfer pricing arrangements, and (2) assessing the Company’s interpretation of existing tax law as well as new and amended tax laws, tax positions taken, associated external counsel opinions, information from tax examinations, relevant court rulings and tax authority settlements.
/s/
We have served as the Company’s auditor since 1990.
February 8, 2024
GLOSSARY
Acquisitions and divestitures: mergers and acquisitions activity, as well as divestitures and other structural changes, including changes in ownership or control in consolidated subsidiaries and nonconsolidated equity investees.
Bottler Case Sales (BCS): measure of physical beverage volume shipped to retailers and independent distributors from both PepsiCo and our independent bottlers.
Bottler funding: financial incentives we give to our independent bottlers to assist in the distribution and promotion of our beverage products.
Concentrate Shipments and Equivalents (CSE): measure of our physical beverage volume shipments to independent bottlers.
Constant currency: financial results assuming constant foreign currency exchange rates used for translation based on the rates in effect for the comparable prior-year period. In order to compute our constant currency results, we multiply or divide, as appropriate, our current year U.S. dollar results by the current year average foreign exchange rates and then multiply or divide, as appropriate, those amounts by the prior year average foreign exchange rates.
Consumers: people who eat and drink our products.
CSD: carbonated soft drinks.
Customers: authorized independent bottlers, distributors and retailers.
Direct-Store-Delivery (DSD): delivery system used by us, our independent bottlers and our distributors to deliver beverages and convenient foods directly to retail stores where our products are merchandised.
Effective net pricing: reflects the year-over-year impact of discrete pricing actions, sales incentive activities and mix resulting from selling varying products in different package sizes and in different countries.
Free cash flow: net cash from operating activities less capital spending, plus sales of property, plant and equipment.
Independent bottlers: customers to whom we have granted exclusive contracts to sell and manufacture certain beverage products bearing our trademarks within a specific geographical area.
Mark-to-market net impact: change in market value for commodity derivative contracts that we purchase to mitigate the volatility in costs of energy and raw materials that we consume. The market value is determined based on prices on national exchanges and recently reported transactions in the marketplace.
NCB: non-carbonated beverage.
Organic: a measure that adjusts for the impacts of foreign exchange translation, acquisitions and divestitures, and where applicable, the impact of the 53rd reporting week. In excluding the impact of foreign exchange translation, we assume constant foreign exchange rates used for translation based on the rates in effect for the comparable prior-year period. See the definition of “Constant currency” for further information.
Total marketplace spending: includes sales incentives and discounts offered through various programs to our customers, consumers or independent bottlers, as well as advertising and other marketing activities.
Transaction gains and losses: the impact on our consolidated financial statements of exchange rate changes arising from specific transactions.
Translation adjustment: the impact of converting our foreign affiliates’ financial statements into U.S. dollars for the purpose of consolidating our financial statements.
Item 7A. Quantitative and Qualitative Disclosures About Market Risk.
Included in “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Our Business Risks.”
Item 8. Financial Statements and Supplementary Data.
See “Item 15. Exhibits and Financial Statement Schedules.”
Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure.
Not applicable.
Item 9A. Controls and Procedures.
(a) Disclosure Controls and Procedures. As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the Exchange Act). Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that as of the end of the period covered by this report our disclosure controls and procedures were effective to ensure that information required to be disclosed by us in reports we file or submit under the Exchange Act is (1) recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and (2) accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.
(b) Management’s Annual Report on Internal Control over Financial Reporting. Our management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rule 13a-15(f) of the Exchange Act. Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we conducted an evaluation of the effectiveness of our internal control over financial reporting based upon criteria established in Internal Control – Integrated Framework (2013) by the Committee of Sponsoring Organizations of the Treadway Commission. Based on that evaluation, our management concluded that our internal control over financial reporting was effective as of December 30, 2023.
Attestation Report of the Registered Public Accounting Firm. KPMG LLP, an independent registered public accounting firm, has audited the consolidated financial statements included in this Annual Report on Form 10-K and, as part of their audit, has issued their report, included herein, on the effectiveness of our internal control over financial reporting.
(c) Changes in Internal Control over Financial Reporting. During our fourth quarter of 2023, we continued migrating certain of our financial processing systems to an Enterprise Resource Planning (ERP) solution. These systems implementations are part of our ongoing global business transformation initiative, and we plan to continue implementing such systems throughout other parts of our businesses in phases over the next several years. In connection with these ERP implementations, we are updating and will continue to update our internal control over financial reporting, as necessary, to accommodate modifications to our business processes and accounting procedures. During 2023, we continued implementing these systems, resulting in changes that materially affected our internal control over financial reporting. These system implementations did not have an adverse effect, nor do we expect will have an adverse effect, on our internal control over financial reporting. In addition, in connection with our 2019 multi-year productivity plan, we continue to migrate to shared business models across our operations to further simplify, harmonize and automate processes. In connection with our 2019 multi-year
productivity plan and resulting business process changes, we continue to enhance the design and documentation of our internal control over financial reporting processes, to maintain effective controls over our financial reporting. These business process changes have not materially affected, and we do not expect them to materially affect, our internal control over financial reporting.
Except with respect to the continued implementation of ERP systems, there have been no changes in our internal control over financial reporting during our fourth quarter of 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. We will continue to assess the impact on our internal control over financial reporting as we continue to implement our ERP solution and our 2019 multi-year productivity plan.
Item 9B. Other Information.
During the 16 weeks ended December 30, 2023, of our directors or executive officers adopted, modified or terminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement” as such terms are defined under Item 408 of Regulation S-K.
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.
Not applicable.
PART III
Item 10. Directors, Executive Officers and Corporate Governance.
Information about our directors and persons nominated to become directors is contained under the caption “Election of Directors” in our Proxy Statement for our 2024 Annual Meeting of Shareholders to be filed with the SEC within 120 days of the year ended December 30, 2023 (the 2024 Proxy Statement) and is incorporated herein by reference. Information about our executive officers is reported under the caption “Information About Our Executive Officers” in Part I of this report.
Information on beneficial ownership reporting compliance will be contained under the caption “Ownership of PepsiCo Common Stock - Delinquent Section 16(a) Reports,” if applicable, in our 2024 Proxy Statement and is incorporated herein by reference.
We have a written code of conduct that applies to all of our employees, including our Chairman of the Board of Directors and Chief Executive Officer, Chief Financial Officer and Controller, and to our Board of Directors. Our Global Code of Conduct is distributed to all employees and is available on our website at http://www.pepsico.com. A copy of our Global Code of Conduct may be obtained free of charge by writing to Investor Relations, PepsiCo, Inc., 700 Anderson Hill Road, Purchase, New York 10577. Any amendment to our Global Code of Conduct and any waiver applicable to our executive officers or senior financial officers will be posted on our website within the time period required by the SEC and applicable rules of The Nasdaq Stock Market LLC.
Information about the procedures by which security holders may recommend nominees to our Board of Directors can be found in our 2024 Proxy Statement under the caption “Board Composition and Refreshment – Shareholder Recommendations and Nominations of Director Candidates” and is incorporated herein by reference.
Information concerning the composition of the Audit Committee and our Audit Committee financial experts is contained in our 2024 Proxy Statement under the caption “Corporate Governance at PepsiCo – Committees of the Board of Directors – Audit Committee” and is incorporated herein by reference.
Item 11. Executive Compensation.
Information about director and executive officer compensation, Compensation Committee interlocks and the Compensation Committee Report is contained in our 2024 Proxy Statement under the captions “2023 Director Compensation,” “Executive Compensation,” “Corporate Governance at PepsiCo – Committees of the Board of Directors – Compensation Committee – Compensation Committee Interlocks and Insider Participation” and “Executive Compensation – Compensation Committee Report” and is incorporated herein by reference.
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters.
Information with respect to securities authorized for issuance under equity compensation plans can be found under the caption “Executive Compensation – Securities Authorized for Issuance Under Equity Compensation Plans” in our 2024 Proxy Statement and is incorporated herein by reference.
Information on the number of shares of PepsiCo Common Stock beneficially owned by each director and named executive officer, by all directors and executive officers as a group and on each beneficial owner of more than 5% of PepsiCo Common Stock is contained under the caption “Ownership of PepsiCo Common Stock” in our 2024 Proxy Statement and is incorporated herein by reference.
Item 13. Certain Relationships and Related Transactions, and Director Independence.
Information with respect to certain relationships and related transactions and director independence is contained under the captions “Corporate Governance at PepsiCo – Related Person Transactions” and “Corporate Governance at PepsiCo – Director Independence” in our 2024 Proxy Statement and is incorporated herein by reference.
Item 14. Principal Accounting Fees and Services.
Information on our Audit Committee’s pre-approval policy and procedures for audit and other services and information on our principal accountant fees and services is contained in our 2024 Proxy Statement under the caption “Ratification of Appointment of Independent Registered Public Accounting Firm – Audit and Other Fees” and is incorporated herein by reference.
PART IV
Item 15. Exhibits and Financial Statement Schedules.
| | | | | |
| (a)1. | Financial Statements |
| The following consolidated financial statements of PepsiCo, Inc. and its affiliates are included herein by reference to the pages indicated on the index appearing in “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations”: |
| Consolidated Statement of Income – Fiscal years ended December 30, 2023, December 31, 2022 and December 25, 2021 |
| Consolidated Statement of Comprehensive Income – Fiscal years ended December 30, 2023, December 31, 2022 and December 25, 2021 |
| Consolidated Statement of Cash Flows – Fiscal years ended December 30, 2023, December 31, 2022 and December 25, 2021 |
| Consolidated Balance Sheet – December 30, 2023 and December 31, 2022 |
| Consolidated Statement of Equity – Fiscal years ended December 30, 2023, December 31, 2022 and December 25, 2021 |
| Notes to the Consolidated Financial Statements, and |
| Report of Independent Registered Public Accounting Firm (PCAOB ID: ). |
| (a)2. | Financial Statement Schedules |
| These schedules are omitted because they are not required or because the information is set forth in the financial statements or the notes thereto. |
| (a)3. | Exhibits |
| See Index to Exhibits. |
Item 16. Form 10-K Summary.
None.
INDEX TO EXHIBITS
ITEM 15(a)(3)
The following is a list of the exhibits filed as part of this Form 10-K. The documents incorporated by reference can be viewed on the SEC’s website at http://www.sec.gov.
EXHIBIT
| | | | | | | | |
| 3.1 | | |
| 3.2 | | |
| 4.1 | PepsiCo, Inc. agrees to furnish to the Securities and Exchange Commission, upon request, a copy of any instrument, not otherwise filed herewith, defining the rights of holders of long-term debt of PepsiCo, Inc. and its consolidated subsidiaries and for any of its unconsolidated subsidiaries for which financial statements are required to be filed with the Securities and Exchange Commission. | |
| 4.2 | | |
| 4.3 | | |
| 4.4 | | |
| 4.5 | | |
| 4.6 | | |
| 4.7 | | |
| 4.8 | | |
| 4.9 | | |
| 4.10 | | |
| 4.11 | | |
| 4.12 | | |
| | | | | | | | |
| 4.13 | | |
| 4.14 | | |
| 4.15 | | |
| 4.16 | | |
| 4.17 | | |
| 4.18 | | |
| 4.19 | | |
| 4.20 | | |
| 4.21 | | |
| 4.22 | | |
| 4.23 | | |
| 4.24 | | |
| 4.25 | | |
| 4.26 | | |
| 4.27 | | |
| 4.28 | | |
| 4.29 | | |
| | | | | | | | |
| 4.30 | | |
| 4.31 | | |
| 4.32 | | |
| 4.33 | | |
| 4.34 | | |
| 4.35 | | |
| 4.36 | | |
| 4.37 | | |
| 4.38 | | |
| 4.39 | | |
| 4.40 | | |
| 4.41 | | |
| 4.42 | | |
| 4.43 | | |
| 4.44 | | |
| 4.45 | | |
| 4.46 | | |
| | | | | | | | |
| 4.47 | | |
| 4.48 | | |
| 4.49 | | |
| 4.50 | | |
| 4.51 | | |
| 4.52 | | |
| 4.53 | | |
| 4.54 | | |
| 4.55 | | |
| 4.56 | | |
| 4.57 | | |
| 4.58 | | |
| 4.59 | | |
| 4.60 | | |
| 4.61 | | |
| 4.62 | | |
| 4.63 | | |
| | | | | | | | |
| 4.64 | | |
| 4.65 | Board of Directors Resolutions Authorizing PepsiCo, Inc.’s Officers to Establish the Terms of the 3.600% Senior Notes due 2024, the 2.625% Senior Notes due 2026, the 4.250% Senior Notes due 2044, the 2.750% Senior Notes due 2025, the 3.500% Senior Notes due 2025, the 4.600% Senior Notes due 2045, the 4.450% Senior Notes due 2046, the 2.850% Senior Notes due 2026, the 0.875% Senior Notes due 2028, the 2.375% Senior Notes due 2026, the 3.450% Senior Notes due 2046, the 4.000% Senior Notes due 2047, the 2.150% Senior Notes due 2024, the 3.000% Senior Notes due 2027, the 7.00% Senior Notes due 2029, Series A, the 5.50% Senior Notes due 2035, Series A, the 7.29% Senior Notes due 2026, the 7.44% Senior Notes due 2026, the 7.00% Senior Notes due 2029, the 5.50% Senior Notes due 2035, the 0.750% Senior Notes due 2027, the 1.125% Senior Notes due 2031, the 2.625% Senior Notes due 2029, the 3.375% Senior Notes due 2049, the 2.875% Senior Notes due 2049, the 0.875% Senior Notes due 2039, the 2.250% Senior Notes due 2025, the 2.625% Senior Notes due 2027, the 2.750% Senior Notes due 2030, the 3.500% Senior Notes due 2040, the 3.625% Senior Notes due 2050, the 3.875% Senior Notes due 2060, the 1.625% Senior Notes due 2030, the 0.250% Senior Notes due 2024, the 0.500% Senior Notes due 2028, the 1.400% Senior Notes due 2031, the 0.400% Senior Notes due 2032, the 1.050% Senior Notes due 2050, the 0.750% Senior Notes due 2033, the 1.950% Senior Notes due 2031, the 2.625% Senior Notes due 2041, the 2.750% Senior Notes due 2051, the 3.600% Senior Notes due 2028, the 4.200% Senior Notes due 2052, the 3.900% Senior Notes due 2032, the 3.200% Senior Notes due 2029, the 3.550% Senior Notes due 2034, the Floating Rate Notes due 2026, the 4.550% Senior Notes due 2026, the 4.450% Senior Notes due 2028, the 4.450% Senior Notes due 2033, the 4.650% Senior Notes due 2053, the Floating Rate Notes due 2024, the 5.250% Senior Notes due 2025 and the 5.125% Senior Notes due 2026, which are incorporated herein by reference to Exhibit 4.4 to PepsiCo, Inc.’s Current Report on Form 8-K filed with the Securities and Exchange Commission on February 28, 2013. | |
| 4.66 | Third Supplemental Indenture, dated as of October 24, 2018, between Pepsi-Cola Metropolitan Bottling Company, Inc. and The Bank New York Mellon Trust Company, N.A., as trustee, to the Indenture dated as of January 15, 1993 between Whitman Corporation and The First National Bank of Chicago, as trustee, which is incorporated herein by reference to Exhibit 4.2 to PepsiCo, Inc.’s Current Report on Form 8-K filed with the Securities and Exchange Commission on October 25, 2018. | |
| 4.67 | Second Supplemental Indenture, dated as of February 26, 2010, among Pepsi-Cola Metropolitan Bottling Company, Inc., PepsiAmericas, Inc. and The Bank New York Mellon Trust Company, N.A., as trustee, to the Indenture dated as of January 15, 1993 between Whitman Corporation and The First National Bank of Chicago, as trustee, which is incorporated herein by reference to Exhibit 4.2 to PepsiCo, Inc.’s Current Report on Form 8-K filed with the Securities and Exchange Commission on March 1, 2010. | |
| 4.68 | First Supplemental Indenture, dated as of May 20, 1999, between Whitman Corporation and The First National Bank of Chicago, as trustee, to the Indenture dated as of January 15, 1993, between Whitman Corporation and The First National Bank of Chicago, as trustee, each of which is incorporated herein by reference to Exhibit 4.3 to Post-Effective Amendment No. 1 to PepsiAmericas, Inc.’s Registration Statement on Form S-8 (Registration No. 333-64292) filed with the Securities and Exchange Commission on December 29, 2005. | |
| 4.69 | | |
| 4.70 | | |
| | | | | | | | |
| 10.1 | | |
| 10.2 | | |
| 10.3 | | |
| 10.4 | | |
| 10.5 | | |
| 10.6 | | |
| 10.7 | | |
| 10.8 | | |
| 10.9 | | |
| 10.10 | | |
| 10.11 | | |
| 10.12 | | |
| 10.13 | | |
| 10.14 | | |
| 10.15 | | |
| 10.16 | | |
| 10.17 | | |
| | | | | | | | |
| 10.18 | | |
| 10.19 | | |
| 10.20 | | |
| 10.21 | | |
| 10.22 | | |
| 10.23 | | |
| 10.24 | | |
| 21 | | |
| 23 | | |
| 24 | | |
| 31 | | |
| 32 | | |
| 97 | | |
| 99.1 | 364-Day Credit Agreement, dated as of May 26, 2023, among PepsiCo, as borrower, the lenders named therein, and Citibank, N.A., as administrative agent, which is incorporated by reference to Exhibit 99.1 to PepsiCo, Inc.’s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 30, 2023. | |
| 99.2 | Five-Year Credit Agreement, dated as of May 26, 2023, among PepsiCo, as borrower, the lenders named therein, and Citibank, N.A., as administrative agent, which is incorporated by reference to Exhibit 99.2 to PepsiCo, Inc.’s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 30, 2023. | |
| 101 | The following materials from PepsiCo, Inc.’s Annual Report on Form 10-K for the fiscal year ended December 30, 2023 formatted in iXBRL (Inline eXtensible Business Reporting Language): (i) the Consolidated Statements of Income, (ii) the Consolidated Statements of Comprehensive Income, (iii) the Consolidated Statements of Cash Flows, (iv) the Consolidated Balance Sheets, (v) the Consolidated Statements of Equity and (vi) Notes to the Consolidated Financial Statements. | |
| 104 | The cover page from the Company’s Annual Report on Form 10-K for the fiscal year ended December 30, 2023, formatted in Inline XBRL and contained in Exhibit 101. | |
*Management contracts and compensatory plans or arrangements required to be filed as exhibits pursuant to Item 15(a)(3) of this report.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, PepsiCo has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Dated: February 8, 2024
| | | | | | | | |
| | |
| PepsiCo, Inc. |
| | |
| By: | /s/ Ramon L. Laguarta |
| | Ramon L. Laguarta |
| | Chairman of the Board of Directors and Chief Executive Officer |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of PepsiCo and in the capacities and on the date indicated. | | | | | | | | |
| | |
| SIGNATURE | TITLE | DATE |
| /s/ Ramon L. Laguarta | Chairman of the Board of Directors | February 8, 2024 |
| Ramon L. Laguarta | and Chief Executive Officer | |
| /s/ James T. Caulfield | Executive Vice President | February 8, 2024 |
| James T. Caulfield | and Chief Financial Officer | |
| /s/ Marie T. Gallagher | Senior Vice President and Controller | February 8, 2024 |
| Marie T. Gallagher | (Principal Accounting Officer) | |
| /s/ Segun Agbaje | Director | February 8, 2024 |
| Segun Agbaje | | |
| /s/ Jennifer Bailey | Director | February 8, 2024 |
| Jennifer Bailey | | |
| /s/ Cesar Conde | Director | February 8, 2024 |
| Cesar Conde | | |
| /s/ Ian M. Cook | Director | February 8, 2024 |
| Ian M. Cook | | |
| /s/ Edith W. Cooper | Director | February 8, 2024 |
| Edith W. Cooper | | |
| /s/ Susan M. Diamond | Director | February 8, 2024 |
| Susan M. Diamond | | |
| /s/ Dina Dublon | Director | February 8, 2024 |
| Dina Dublon | | |
| /s/ Michelle Gass | Director | February 8, 2024 |
| Michelle Gass | | |
| /s/ Dave J. Lewis | Director | February 8, 2024 |
| Dave J. Lewis | | |
| /s/ David C. Page | Director | February 8, 2024 |
| David C. Page | | |
| /s/ Robert C. Pohlad | Director | February 8, 2024 |
| Robert C. Pohlad | | |
| /s/ Daniel Vasella | Director | February 8, 2024 |
| Daniel Vasella | | |
| /s/ Darren Walker | Director | February 8, 2024 |
| Darren Walker | | |
| /s/ Alberto Weisser | Director | February 8, 2024 |
| Alberto Weisser | | |
Similar companies
See also LVMH MOET HENNESSY LOUIS VUITTON
See also COCA COLA CO -
Annual report 2024 (10-K 2024-12-31)
Annual report 2025 (10-Q 2025-06-27)
See also DIAGEO PLC
See also Keurig Dr Pepper Inc. -
Annual report 2022 (10-K 2022-12-31)
Annual report 2025 (10-Q 2025-06-30)
See also PERNOD RICARD S A /FI